glp-1 receptor agonist news agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Side Effects: Endocrine Society Journals
Description
This often relates to reduced caloric intake rather than a direct drug effect
Garcia Luna, C
The US contributed the majority of the regions revenue, accounting for 95.2% of the weight-loss medication segment
Whether you are on a GLP-1 medication or not, the nutrition principles for preserving lean mass are the same
If youre considering Ozempic, talk with your provider about your health history, current meds, and concerns
